A one day workshop on Careers in Clinical Research was conducted on 8^th March 2014 at ACRI.

The speaker for the day, Dr. Smita Singh gave a magnificent presentation on Drug Discovery & Development and Careers in Clinical Research. Students actively participated in the workshop and also clarified their queries w.r.t the course duration, fee, hostel…etc. They were highly motivated and were optimistic about taking up the course post the completion of their Bachelors. 

Today's group discussion topic was "SCOPE OF PHASE I TRIALS IN INDIA''.

Too much protein in middle age ' as bad as smoking '

Middle-aged people who eat a lot of protein, particularly animal-derived, have increased cancer risk and shorter lives, although moderate protein intake may benefit older people.

New Interferon-Free Drugs for Hep C Show High Cure Rates

Interferon has been the primary treatment for chronic hepatitis C for 2 decades, but new drugs promise better results with fewer adverse effects.

In the PEARL-III trial, treatment-naïve noncirrhotic adults with chronic genotype 1b (GT1b) hepatitis C were treated with an investigational all-oral interferon-free treatment from AbbVie plus ribavirin. After 12 weeks of treatment, sustained virologic response rates reached 99.5%. Even in difficult-to-treat cirrhotic patients, response rates reached 92% to 96%.

Batch-20 students of ACRI, enacted an attractive, dramatic role-play on technical case study.

A very good illustration of industry case study by students of ACRI (batch-20).

Gloria Of batch 19, gave a very good presentation on topic of SUBJECT RECRUITMENT AND RETENTION IN CLINICAL RESEARCH.